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Day 1 (7/19/2022)
Admission H&P
CC: Chest pain and body ache
HPI: 31 years old male presenting to the ED with chest pain and body ache. He reported
experiencing pain on his arms and legs while at work yesterday and it had gotten worsened
today accompanied with chest pain and tightness, which prompted him to come to the ED.
Patient has sickle cell disease with severe vaso-occlusive episodes requiring hospitalization
about 3-4 times a year. He has had 2 crisis episodes requiring hospitalization this year with last
hospitalization about 2 months ago. Patient recently moved to Stockton last month and is trying
to establish care with a new PCP as he has ran out of his oxycodone and missed his blood
transfusion this month. He has some Norco left that gets him through the past few days without
oxycodone. On typical days, he reported taking his oxycodone twice and on average 4 tablets of
Norco daily that control his pain well. He is also inquiring about getting labs for his hydroxyurea
as his previous PCP initiated it 6 months ago and inform him that he will need to obtain some
labs after 6 months of therapy.
PMH: Sickle cell anemia on monthly exchange transfusion, hypertension
Surgical history: Splenectomy in 1998
Social History: Denies alcohol, tobacco, or recreational drug use. Lives with wife.
Home medications:
Amlodipine 5 mg - 1 tablet PO daily
Lisinopril 40 mg - 1 tablet PO daily
Hydroxyurea 500 mg - 2 capsules PO daily
12 HR Oxycodone ER 40 mg - 1 tablet PO BID
Hydrocodone/acetaminophen 5/325 mg - 1-2 tablets q6h PRN for pain
Physical Exam:
Vital Signs upon admission: 36.6 C, Pulse 106, RR 18, BP 149/87, 98% on RA, Wt 140 lbs, Ht
5'8"
General: Alert and oriented, in acute distress
HEENT: Normocephalic, oral mucosa is moist, extraocular movements are intact, Normal
conjunctiva.
Respiratory: Diminished air entry bilaterally, diffuse wheezing and coarse breath sounds
Cardiovascular: Rapid rate, Regular rhythm, No murmur, No gallop,
Gastrointestinal: Soft, tender, Non-distended, Normal bowel sounds.
Lymphatics: No lymphadenopathy
Extremities: Good pulses equal in all extremities, Normal peripheral perfusion, No edema.
Reports pain 9/10 in arms, legs, chest and generalized joint ache.
Neurologic: Appears tired, Oriented, No focal deficits, Cranial Nerves II-XII are grossly intact.
Assessment/Plan:
1. Vaso-occlusive crisis: Oxycodone ER and Norco are non-formulary medications. Will convert
pain medications to MS Contin 60 mg PO BID and Dilaudid 2 mg IV q6h PRN. Start IV fluid.
2. Acute chest syndrome 2/2 pneumonia: Start IV empiric antibiotics.
3. Elevated LFT: possibly due to iron overload. Will continue to monitor and defer treatment to
primary care.
Other Work-ups

ECG: Normal sinus rhythm. No cardiac abnormality.
Chest X-ray: Opacities concerning for pneumonia. No pleural effusion.

Day 2 (7/20/2022)
Inpatient Progress Note
Patient was seen at bedside. No acute event overnight. Patient was comfortable but very sleepy this
morning. RN reported patient has not been needing the PRN Dilaudid as much. He has only
received 1 dose of Dilaudid around admission.

Physical Exam:
Neuro: non-focal, A&Ox3
HEENT: normocephalic, atraumatic, no scleral icterus, or conjunctival injection
Neck: supple, no rigidity, no lymphadenopathy, bruits, or thyromegaly
Lungs: expiratory wheezing throughout, improved breath sounds
CV: RRR, normal S1/S2, no gallops, no jugular venous distention
GI: no distention, positive bowel sounds, no masses
Extremity: no cyanosis, clubbing, or distal pitting edema
Skin: warm and dry, no ulcerations
Assessment/Plan:
1. Vaso-occlusive crisis: better pain control with inpatient pain medications. Continue to monitor
and discharge tomorrow if stable.
2. Acute chest syndrome 2/2 pneumonia: On IV Rocephin and azithromycin. Complete 7-day
course.
3. Elevated LFT/Iron overload: Stable. Defer management to primary care.

Day 3 (7/21/22)
Discharge Summary
Admitting complaint: Chest pain and body ache
Discharge diagnosis: Vaso-occlusive crisis and acute chest syndrome secondary to
pneumonia
Course of care: Patient presented to ED with signs and symptom of vaso-occlusive crisis and
acute chest syndrome. During hospitalization, patient received IV pain medications and
transitioned to PO pain medications, which resolved the pain crisis. Patient was also initiated on
antibiotics for pneumonia and received 2 days of IV ceftriaxone and IV azithromycin.
Past medical history: Sickle cell anemia on monthly exchange transfusion (goal Hgb 9-10
g/dl), hypertension
Discharge Instructions: Complete total 7 days of antibiotic. Continue all home medications.
New medications for discharge: Levofloxacin 750 mg PO daily x 5 days, azithromycin 250 mg
PO daily x 5 days, 12 HR oxycodone ER 40 mg PO BID, hydrocodone/acetaminophen 5/325
mg PO q6h PRN pain
Follow-up: Appointment with new PCP, Dr. Estella Moon, had been scheduled on 7/28/2022.

Day 7 (7/25/2022)
Admission H&P
CC: right-sided weakness and facial droop

HPI: 31 years old male with known sickle cell disease brought in by ambulance to the ED with
right-sided weakness and facial droop. The wife reported the symptoms started about an hour
ago when they were having breakfast and she immediately called 911. He is paretic on the right
side with decreased strength in the upper and lower extremities, he has right-sided facial
weakness and garbled speech. Patient had a recent ED visit last week for vaso-occlusive crisis
and pneumonia. He was hospitalized for 2 days to get his pain under control and was then
discharged home to finish antibiotic course. His wife expressed that after discharge, he doesn't
seem to get better. The antibiotics he was prescribed last week didn't seem to resolve his
pneumonia despite being compliant to it. He has low appetite and last night, he felt chills and
spiked a fever. His wife told him to go back to ED but he refused and wanted to wait until the
morning. Upon admission, oxygen saturation was found 87% on room air and patient was
started on 2 L nasal cannula.
PMH: Sickle cell anemia on monthly exchange transfusion (goal Hgb 9-10 g/dl), hypertension
Surgical history: Splenectomy in 1998
Social History: Denies alcohol, tobacco, or recreational drug use. Lives with wife.
Physical Exam:
Vital Signs upon admission: 38.6 C, Pulse 112, RR 28, BP 192/108, SpO2 87% on room air, Wt
140 lbs, Ht 5'8", pain 8/10
General appearance: 31 year old male of appropriate height and weight in acute distress.
Head: Normocephalic, non-traumatic, no masses or lesions
Eyes: Visual fields intact, PERRLA, red reflex present. Discs flat with sharp margins, vessels
present without defects
Neck: Supple without lymphadenopathy, masses, or thyromegaly. Carotid pulses 2+ bilaterally,
no bruits, full ROM, trachea midline, no retraction, lesions, masses or tenderness
Back, thorax & lungs: Lungs sounds with crackles throughout and decreased intensity of breath
sounds. Respirations are labored and rapid. Symmetrical chest wall expansion with use of some
accessory muscles, coughing copious green purulent sputum.
Cardiovascular: Regular rhythm, tachycardic, no systolic ejection murmur, rubs, gallops
Extremities: Extremity size symmetric without swelling, temperature warm and equal bilaterally.
All pulses present, 2+ and equal bilaterally. Reports pain 8/10 in left arm, left leg, chest and
generalized joint ache.
Skin: Skin color pale and diaphoretic.
Musculoskeletal: Right sided paresis. Right sided facial weakness. Joints and muscles
symmetric in size, no swelling, masses, deformity or tenderness to palpation; no heat or
swelling of joints; limited range of motion with the right arm and right leg; muscle strength 3/5 on
right side, 5/5 on left.
Nervous system: CN II-XII grossly intact, alert, cooperative, speech is unclear, oriented x2,
NIHSS score 12.
Assessment/Plan:
1. Ischemic stroke: Left sided ischemic cerebral vascular accident. Consult neurology and
pharmacy for tPA eligibility.
2. Sepsis 2/2 pneumonia: Hospital-acquired from recent admission and positive COVID-19 test.
Start empiric antibiotics and COVID standard of care. Continue nasal canula and titrate to goal
oxygen saturation 90-92%.
3.Sickle cell crisis: Start IV fluid and blood transfusion. Continue home medications.
4. Elevated LFT: Sign of liver injury secondary to iron overload. Consult pharmacy to start
treatment.
5. HTN: continue home medications.
Other Work-ups

CT Head: left middle cerebral artery (MCA) infarction. No intracranial hemorrhage or mass
effect.
Chest X-ray: Multifocal patchy bilateral airspace opacities, concerning for multifocal infection.
COVID-19 is most likely but bacterial involvement cannot be excluded. No concern of
pulmonary embolism.

Summary of Labs/Vitals/Cultures/Glucose/Inpatient Medications:
Actual BW: 63.6 kg
IBW: 68.4 kg (BMI 21.3)
Labs:
CBC
WBC (cells/ml)
Hgb (g/dl)
Hct (%)
Plt
MCV (fl)
MCH (pg)
MCHC (%)
Reticulocyte (cells/mm3)
Segment Neutrophil (%)
Bands (%)
ANC**(cells/ul)
Basophils (%)
Eosinophils (%)
Lymphocytes (%)
Monocytes (%)
Coag
PT
INR
BMP
Na
K
Cl
CO2
Glu
BUN
SCr
CrCl**
Tbili
ALT
AST
Alkphos
Alb
Others
TC
HDL
LDL
TG
SARS-CoV-2 PCR
Troponin
Serum ferritin (ng/dl)

7/19/2022

7/20/2022

7/21/2022

7/25/2022

9,200
8.3
25
231,000
99
30
32
156,000
65
5.3
6,467.6
1
1.5
25
3

9,800
8.2
24.6
250,000
92
32
36
148,000
69
5.8
7,330.4
1
2
36
5

8,900
8.5
26.2
280,000
94
36
37
161,000
68
5.9
6,577.1
1
1
32
4

15,200
8.1
24.3
420,000
89
34
36
157,000
79
6.2
12950.4
2
3.5
67
6

11
1.1
138
3.8
107
28
82
8
0.7
>120
1.5
66
46
215
2.6
187
32
97
128
Negative
<0.01 x2
5327.3

12
0.9
141
3.7
104
24
79
7
0.7
>120
1.4
59
37
214

137
4.1
106
23
89
9
0.8
>120
1.5
61
39
205

142
3.9
102
25
103
8
0.6
>120
1.6
69
42
218
2.4

Positive
5428.4

CRP (mg/L)
Sputum culture
Blood culture #1
Blood culture #2
**Students are not given these calculated numbers (i.e. CrCl, ANC)
Vitals/Pain
Previous Admission

48
Pending
Pending
Pending

Additional Scheduled Medications (on top of home medications and discharge antibiotics
from previous admission):
IV fluid 1000 mL on both admission
2 units PRBC on stroke admission
2 L NC on stroke admission
MS Contin 60 mg BID and Dilaudid 2 mg q6h PRN on previous admission
Recent vaccine:
- Moderna COVID vaccine (8/3/21, 10/01/21, 3/15/22)
- Influenza (10/2/21)
- Hib (8/3/1998)
- Hep B (9/19/11, 12/8/11, 1/25/13)
- MenACWY (9/19/11, 12/8/11, 7/19/2016)
- MenB (9/19/11, 12/8/11, 1/25/13, 7/19/2016)
- Tdap (7/17/01), Td (9/19/11)
- PPSV23 (12/10/20)
Student Instructions
1. Please provide comprehensive assessment and plan for the main problems with specific
instructions as follows. Be very clear on timing of medication administration or
initiation and drug forms/strengths.
• Acute ischemic stroke/hypertensive crisis: provide assessment for patient’s tPA eligibility
and other necessary immediate plan (within 24 hours) surrounding tPA administration
(do not worry about providing long-term plan as your work-up)
• COVID-19 and bacterial pneumonia: provide antibiotics recommendations for bacterial
pneumonia and guideline-recommended therapy for hospitalized patients with COVID-19
pneumonia. In addition, provide comprehensive inpatient care plan pertinent to the
problem.
• Sickle cell anemia: provide plans for long-term sickle cell anemia management to reduce
incidence of crisis or complications, include necessary vaccinations with appropriate
administration timings and plans.
2. Please review patient’s course of hospitalization or previous admission (including
appropriateness of medications initiated, monitoring during hospitalization, or any necessary
follow-ups) and review appropriate clinical guidelines/literatures carefully to assist in
responding to the discussion questions.
Discussion Questions
1. Assuming Tony is eligible and received tPA, please provide treatment plan 24 hours after
tPA administration for optimal management and secondary prevention of ischemic stroke
(include necessary pharmacological, nonpharmacological, goal of therapy,monitoring, etc.).
2. Assuming Tony was not indicated for and did not receive tPA, please provide immediate and
long-term treatment plan for optimal management of ischemic stroke (include necessary
pharmacological, nonpharmacological, goal of therapy, monitoring, etc.).
3. Do you agree or disagree with the inpatient discharge treatment plan for pneumonia from
previous admission? Please provide rationale.
4. What is the role of baricitinib or tocilizumab in management of COVID-19 infection (i.e. what
are the benefits found in studies for these drugs)? Would you recommend either or both
medications for Tony at this time? Provide rationales (i.e. what are some indications and
contraindications/ precautions for initiating the medications).
5. Do you agree with the opioid conversion (i.e. rom PO oxycodone ER and PO Norco PRN to
PO MS Contin and IV Dilaudid PRN) on previous admission? Please provide your rationale.
6. What is the role of naloxone distribution in community programs as preventative strategy?
Would you recommend offering naloxone for Tony (provide rationale).

